共 288 条
[1]
Hill NR(2016)Global prevalence of chronic kidney disease—a systematic review and meta-analysis PLoS ONE 11 141-148
[2]
Fatoba ST(2012)Understanding the effects of chronic kidney disease on cardiovascular risk: are there lessons to be learnt from healthy kidney donors? J Hum Hypertens 26 1294-1304
[3]
Oke JL(2019)Chronic kidney disease diagnosis and management: a review JAMA 322 1436-1446
[4]
Hirst JA(2020)Dapagliflozin in patients with chronic kidney disease N Engl J Med 383 325-338
[5]
O'Callaghan CA(2016)TGF-beta: the master regulator of fibrosis Nat Rev Nephrol 12 953-962
[6]
Lasserson DS(2017)Anti-TGF-beta1 antibody therapy in patients with diabetic nephropathy J Am Soc Nephrol 28 101-106
[7]
Moody WE(2012)The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair Mol Cell Endocrinol 359 15-295
[8]
Chue CD(2009)Activin signaling as an emerging target for therapeutic interventions Cell Commun Signal 7 285-144
[9]
Inston NG(2013)The activins and their binding protein, follistatin-diagnostic and therapeutic targets in inflammatory disease and fibrosis Cytokine Growth Factor Rev 24 136-37
[10]
Edwards NC(2020)The emerging role of activins in renal disease Curr Opin Nephrol Hypertens 29 25-366